Business Daily.
.
Business Mentor
A+ R A-

Helsinn and Chugai Pharma Marketing Enter into Agreement for Rights of Anamorelin, Currently in Development for Treatment of Anorexia-Cachexia Syndrome Related to Non-small Cell Lung Cancer in top EU Markets

12-11-2013 Author: Australian Business PR - Health News
E-mail Print PDF
LUGANO, Switzerland, November 12, 2013 /PRNewswire/ -- Swiss Pharma Group Helsinn seals an alliance with Japanese company Chugai by granting exclusive distribution & licensing rights to commercialize its innovative phase III ghrelin receptor agonist in Germany,......
More...

More Articles...

Page 680 of 1906

Business Daily Media